ArgáMedtech

Developing the Next generation of PFA for Cardiac Ablation

[ArgáMedtech @ArgaMedtech]

We are pleased to share that we closed a €54M oversubscribed Series B raise to advance our innovative Pulsed Field Ablation technology for treating #atrialfibrillation in the US and EU.
Learn more in our press release: https://t.co/1Xsncm43MO

[ArgáMedtech @ArgaMedtech]

https://t.co/ISEmroAkvb

[ArgáMedtech @ArgaMedtech]

Argá Medtech to present its CSE PFA platform at Stanford Biodesing New Arrhythmia technologies
https://t.co/UeXc4siN4I

[ArgáMedtech @ArgaMedtech]

Excited to share our poster presentation on Coherent Sine Burst Electroporation's first 5 patient case studies and 60-day follow-up at the AF Symposium in Boston.

#AFSymposium2023 #Arga #ArgaMedtech

[ArgáMedtech @ArgaMedtech]

News from #JPM2023!

Raised €10 Mil & achieved first-in-human in just 20 months with our Coherent Sine Burst Electroporation (#CSE) System for atrial fibrillation (#Afib) patients.

➡️ More by @MDDIonline with CEO David Neale: https://t.co/r924lQDF5F

[ArgáMedtech @ArgaMedtech]

Congrats to our CEO David Neale for being one of the 30 #innovators to watch in 2022 - according to @Dsiliconreview.

🎙Learn more about #Arga in this Q&A with David: https://t.co/gVcbkKtcd2
💡Full list of innovators at: https://t.co/1kuD4WWmd5

#Arga #Medtech #Startups

[ArgáMedtech @ArgaMedtech]

Thank you @holoniq for featuring us among the 200 most promising European #HealthTech #startups.

👉 Read more in the report and meet our fellow nominees at: https://t.co/GWsMKH6F74

#Arga #Medtech #Innovation #Europe

[ArgáMedtech @ArgaMedtech]

https://t.co/ivbKXWTvma

[ArgáMedtech @ArgaMedtech]

Thank you @MedTechOutlook for electing us as one of the top 10 #MedTech #startups in #Europe!

Atrial Fibrillation affects 33M + people worldwide, and treatments have a long-term success of 50-70%. Argá's technology addresses this issue.

➡️ More on https://t.co/UfLxklAh8U

[ArgáMedtech @ArgaMedtech]

We are excited to participate in @lsintelligence #Medtech Summit, an incredible opportunity to connect with other innovators and world-class investors.

📍 Check out our David Neale, CEO & Co-Founder presentation on Sept. 23 at 3 pm BST

#LSIEurope22 #MedicalDevices #Cardiology

[Earlybird VC @EarlybirdVC]

Atrial fibrillation is the most common irregular #heartbeat type and can lead to stroke or heart failure (@MayoClinic).

@ArgaMedtech developed a #CSE pulsed field ablation catheter, soon to start EU first-in-human #trial, to improve existing treatments🫀

✍️ ⬇️ @Medtech_Insight

[ArgáMedtech @ArgaMedtech]

Argá Medtech to present at LSI Emerging Medtech Euorpe 2022
https://t.co/yZcvpSx3O9

[ArgáMedtech @ArgaMedtech]

https://t.co/YTsSYmXb4g

[ArgáMedtech @ArgaMedtech]

https://t.co/ZAOssGFzeP

[ArgáMedtech @ArgaMedtech]

https://t.co/h9bcXw3RBJ

[ArgáMedtech @ArgaMedtech]

Great interest following the presentation @HRS2022

[ArgáMedtech @ArgaMedtech]

https://t.co/qxgxwNMxBE #HRS2022